Niosomal Plumbagin with Reduced Toxicity and Improved Anticancer Activity in BALB/C Mice

R. A. Raja Naresh, N. Udupa, P. Uma Devi

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Plumbagin niosomes were prepared using a lipid layer hydration method, and drug entrapment was measured. The acute toxicity studies were conducted following treatment with free and niosomal plumbagin. The antitumour activity of niosomal plumbagin in a solid tumour (sarcoma-180) and Ehrlich ascites model was evaluated. Niosome-encapsulated plumbagin was less toxic than free drug. The antitumour activity of the drug was also better after encapsulation. The better anticancer activity can be justified with the help of LD50 survival studies and study of tumour volume doubling time.

Original languageEnglish
Pages (from-to)1128-1132
Number of pages5
JournalJournal of Pharmacy and Pharmacology
Volume48
Issue number11
Publication statusPublished - 1996

Fingerprint

Inbred BALB C Mouse
Liposomes
Sarcoma 180
Poisons
Lethal Dose 50
Tumor Burden
Ascites
Pharmaceutical Preparations
Antineoplastic Agents
Lipids
plumbagin
Neoplasms

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science

Cite this

@article{bd486f0526684c8cb3fb1e8545e6cec5,
title = "Niosomal Plumbagin with Reduced Toxicity and Improved Anticancer Activity in BALB/C Mice",
abstract = "Plumbagin niosomes were prepared using a lipid layer hydration method, and drug entrapment was measured. The acute toxicity studies were conducted following treatment with free and niosomal plumbagin. The antitumour activity of niosomal plumbagin in a solid tumour (sarcoma-180) and Ehrlich ascites model was evaluated. Niosome-encapsulated plumbagin was less toxic than free drug. The antitumour activity of the drug was also better after encapsulation. The better anticancer activity can be justified with the help of LD50 survival studies and study of tumour volume doubling time.",
author = "{Raja Naresh}, {R. A.} and N. Udupa and {Uma Devi}, P.",
year = "1996",
language = "English",
volume = "48",
pages = "1128--1132",
journal = "Journal of Pharmacy and Pharmacology",
issn = "0022-3573",
publisher = "Pharmaceutical Press",
number = "11",

}

Niosomal Plumbagin with Reduced Toxicity and Improved Anticancer Activity in BALB/C Mice. / Raja Naresh, R. A.; Udupa, N.; Uma Devi, P.

In: Journal of Pharmacy and Pharmacology, Vol. 48, No. 11, 1996, p. 1128-1132.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Niosomal Plumbagin with Reduced Toxicity and Improved Anticancer Activity in BALB/C Mice

AU - Raja Naresh, R. A.

AU - Udupa, N.

AU - Uma Devi, P.

PY - 1996

Y1 - 1996

N2 - Plumbagin niosomes were prepared using a lipid layer hydration method, and drug entrapment was measured. The acute toxicity studies were conducted following treatment with free and niosomal plumbagin. The antitumour activity of niosomal plumbagin in a solid tumour (sarcoma-180) and Ehrlich ascites model was evaluated. Niosome-encapsulated plumbagin was less toxic than free drug. The antitumour activity of the drug was also better after encapsulation. The better anticancer activity can be justified with the help of LD50 survival studies and study of tumour volume doubling time.

AB - Plumbagin niosomes were prepared using a lipid layer hydration method, and drug entrapment was measured. The acute toxicity studies were conducted following treatment with free and niosomal plumbagin. The antitumour activity of niosomal plumbagin in a solid tumour (sarcoma-180) and Ehrlich ascites model was evaluated. Niosome-encapsulated plumbagin was less toxic than free drug. The antitumour activity of the drug was also better after encapsulation. The better anticancer activity can be justified with the help of LD50 survival studies and study of tumour volume doubling time.

UR - http://www.scopus.com/inward/record.url?scp=0030276749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030276749&partnerID=8YFLogxK

M3 - Article

VL - 48

SP - 1128

EP - 1132

JO - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

SN - 0022-3573

IS - 11

ER -